| Valid Data Submission Method(s) | Measure Type | High Priority Measure? | NQS Domain | Specialty Measure Sets |
|---|---|---|---|---|
| Registry | Outcome | No | Effective Clinical Care |
Measure Description
Percentage of patients treated for varicose veins (CEAP C2-S) who are treated with saphenous ablation (with or without adjunctive tributary treatment) that report an improvement on a disease specific patient reported outcome survey instrument after treatment
Instruction
This measure is to be reported each time a saphenous ablation procedure is performed for the treatment of varicose veins during the performance period. This measure may be reported by eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding.
Denominator
All patients who are treated for varicose veins with saphenous ablation and who receive an outcomes survey before and 3-6 months after treatment
Denominator Criteria (Eligible Cases):
All patients, regardless of age
AND
Diagnosis for varicose veins (ICD-10-CM): I83.811, I83.812, I83.813, I83.819
AND
Patient procedure during the performance period (CPT): 36475, 36478
Numerator
Patients whose outcome survey score improved when assessed 3-6 months following treatment
Definition:
Outcome Survey – A normalized and validated outcome survey developed for the patient reported outcomes for saphenous vein ablation. The disease specific standardized outcome survey utilized must be documented in the medical record. Examples of outcome surveys include, but are not limited to:
•Venous Insufficiency Epidemiological and Economic Study-Quality of Life (VEINES-QOL)
•Chronic Venous Insufficiency Questionnaire (CIVIQ)
•Aberdeen Varicose Veins Questionnaire (AVVQ)
•Specific Quality of Life and Outcome Response – Venous (SQOR-V)
Numerator Options:
Performance Met: Patient survey score improved from baseline following treatment (G9603)
OR
Denominator Exception: Patient survey results not available (G9604)
OR
Performance Not Met: Patient survey score did not improve from baseline following treatment (G9605)